AstraZeneca Pharma
BSE: 506820 | NSE: ASTRAZEN | ISIN: INE203A01020 | Pharmaceuticals
 |
Quarterly Results of AstraZeneca Pharma |
------------------- in Rs. Cr. ------------------- |
| ||||||||||
|
||||||||||
| Sep '08 | Dec '08 | Mar '09 | Jun '09 | Sep '09 | ||||||
|
||||||||||
| Sales Turnover | 90.46 | 97.01 | 80.23 | 99.22 | 100.94 | |||||
| Other Income | 2.63 | 5.70 | 2.74 | 1.14 | 0.70 | |||||
| Total Income | 93.09 | 102.71 | 82.97 | 100.37 | 101.64 | |||||
| Total Expenses | 61.08 | 64.20 | 69.41 | 74.81 | 81.23 | |||||
| Operating Profit | 29.38 | 32.81 | 10.82 | 24.41 | 19.71 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 32.01 | 38.51 | 13.56 | 25.55 | 20.41 | |||||
| Interest | 1.26 | 1.26 | 0.14 | -- | -- | |||||
| PBDT | 30.75 | 37.25 | 13.42 | 25.56 | 20.40 | |||||
| Depreciation | 1.94 | 1.98 | 1.46 | 1.52 | 1.53 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | 28.81 | 35.27 | 11.96 | 24.04 | 18.87 | |||||
| Tax | 10.34 | 12.35 | 4.69 | 8.76 | 5.90 | |||||
| Net Profit | 18.47 | 22.92 | 7.27 | 15.28 | 12.97 | |||||
| Prior Years Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share | 7.39 | 9.17 | 2.91 | 6.11 | 5.19 | |||||
| Book Value | -- | -- | -- | -- | -- | |||||
| Equity | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | |||||
| Reserves | -- | -- | -- | -- | -- | |||||
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore AstraZeneca connections | ||||||||||
| ||||||||||
